PMID- 10845917 OWN - NLM STAT- MEDLINE DCOM- 20000810 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 95 IP - 12 DP - 2000 Jun 15 TI - Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. PG - 3832-9 AB - Lymphopenia and immune deficiency are significant problems following allogeneic hematopoietic cell transplantation (HCT). It is largely assumed that delayed immune reconstruction is due to a profound decrease in thymus-dependent lymphopoiesis, especially in older patients, but apoptosis is also known to play a significant role in lymphocyte homeostasis. Peripheral T cells from patients who received HCT were studied for evidence of increased cell death. Spontaneous apoptosis was measured in CD3(+) T cells following a 24-hour incubation using 7-amino-actinomycin D in conjunction with the dual staining of cell surface antigens. Apoptosis was significantly greater among CD3(+) T cells taken from patients 19-23 days after transplantation (30.4% +/- 12.5%, P <.05), and 1 year after transplantation (9.7% +/- 2.8%, P <.05) compared with healthy controls (4.0% +/- 1.5%). Increased apoptosis occurred preferentially in HLA (human leukocyte antigen)-DR positive cells and in both CD3(+)/CD4(+) and CD3(+)/CD8(+) T-cell subsets, while CD56(+)/CD3(-) natural killer cells were relatively resistant to apoptosis. The extent of CD4(+) T-cell apoptosis was greater in patients with grade II-IV acute graft-versus-host disease (GVHD) (33. 9% +/- 11.3%) compared with grade 0-I GVHD (14.6 +/- 6.5%, P <.05). T-cell apoptosis was also greater in patients who received transplantations from HLA-mismatched donors (39.5% +/- 10.4%, P <. 05) or HLA-matched unrelated donors (32.1% +/- 11.4%, P <.05) compared with patients who received transplantations from HLA-identical siblings (19.6% +/- 6.7%). The intensity of apoptosis among CD4(+) T cells was significantly correlated with a lower CD4(+) T-cell count. Together, these observations suggest that activation of T cells in vivo, presumably by alloantigens, predisposes the cells to spontaneous apoptosis, and this phenomenon is associated with lymphopenia. Activation-induced T-cell apoptosis may contribute to delayed immune reconstitution following HCT. (Blood. 2000;95:3832-3839) FAU - Lin, M T AU - Lin MT AD - Fred Hutchinson Cancer Research Center, Division of Clinical Research, and the University of Washington School of Medicine, Seattle, WA 98109-1024, USA. FAU - Tseng, L H AU - Tseng LH FAU - Frangoul, H AU - Frangoul H FAU - Gooley, T AU - Gooley T FAU - Pei, J AU - Pei J FAU - Barsoukov, A AU - Barsoukov A FAU - Akatsuka, Y AU - Akatsuka Y FAU - Hansen, J A AU - Hansen JA LA - eng GR - AI33484/AI/NIAID NIH HHS/United States GR - CA15704/CA/NCI NIH HHS/United States GR - CA18029/CA/NCI NIH HHS/United States GR - etc. PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antigens, CD) RN - 0 (CD3 Complex) RN - 0 (Fluorescent Dyes) RN - 0 (HLA-DR Antigens) RN - 1CC1JFE158 (Dactinomycin) RN - 7240-37-1 (7-aminoactinomycin D) SB - IM MH - Acute Disease MH - Adult MH - Antigens, CD/blood MH - Apoptosis/*immunology MH - CD3 Complex/blood MH - Cells, Cultured MH - Dactinomycin/analogs & derivatives/pharmacology MH - Fluorescent Dyes MH - Graft vs Host Disease/blood/*immunology MH - HLA-DR Antigens/blood MH - *Hematopoietic Stem Cell Transplantation MH - Histocompatibility Testing MH - Humans MH - In Situ Nick-End Labeling MH - Middle Aged MH - T-Lymphocytes/drug effects/*immunology/pathology MH - Transplantation, Homologous/*immunology EDAT- 2000/06/14 09:00 MHDA- 2000/08/12 11:00 CRDT- 2000/06/14 09:00 PHST- 2000/06/14 09:00 [pubmed] PHST- 2000/08/12 11:00 [medline] PHST- 2000/06/14 09:00 [entrez] AID - S0006-4971(20)63954-4 [pii] PST - ppublish SO - Blood. 2000 Jun 15;95(12):3832-9.